Phase 1 Safety and Pharmacodynamic Results of VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Development for Thyroid Eye Disease (TED) (P3-9.007)
A. She, Barrett Katz, R. Summerfelt, Denis J. O'Shaughnessy, B. Dickinson, K. Foster, V. Bedian
{"title":"Phase 1 Safety and Pharmacodynamic Results of VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Development for Thyroid Eye Disease (TED) (P3-9.007)","authors":"A. She, Barrett Katz, R. Summerfelt, Denis J. O'Shaughnessy, B. Dickinson, K. Foster, V. Bedian","doi":"10.1212/wnl.0000000000202052","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":334567,"journal":{"name":"Sunday, April 23","volume":"38 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sunday, April 23","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/wnl.0000000000202052","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
